Amit Patel founded this pharmaceuticals manufacturer in 2001, making only one drug. Today, Auden McKenzie sells 65 licensed products in Britain, 15 in continental Europe, and one in America. The northwest London firm’s products are used for pain control, epilepsy and cardiovascular problems, and sold to pharmacies and health services, including the NHS. Despite sensitivities in its sector about profits, Patel says the firm’s healthy margins are key to funding improvements in products and technology. Profits rose 168% a year, from £820,000 in 2007 to £15.8m in 2010.
This profile reflects the company at time of publication and does not reflect any changes that may have subsequently occurred. Fast Track and its sponsors do not endorse, guarantee or recommend investment in any of the companies.